Abstract:Introduction. Pheochromocytomas are catecholamine-secreting tumors arising from chromaffin cells of the adrenal gland. Surgery is the only curative treatment with a high biochemical cure rate, low mortality and high risk of perioperative complications. Objectives. To study the demographic characteristics of patients with pheochromocytoma and to identify the risk factors for perioperative complications, treatment outcomes, and aggressive behavior of the tumor. Methodology. We retrospectively studied the data of pheochromocytoma patients registered from 2012 to 2022. Results. In our study, a total of 30 patients with pheochromocytoma were included. The mean age of presentation was 35 ± 12.8 years. Fifty-six percent were females, and the sex ratio was 1.3:1. Pheochromocytoma spells (60%) was the most common complaint, followed by abdominal pain (53%), orthostatic complaints (10%) and incidentalomas (6%). The baseline mean 24-hour urinary total metanephrines was 2963.7 ± 2658 mcg/24 hours, and the mean tumor size was 7.3±0.53 cm. Forty-three percent of patients underwent laparoscopic adrenalectomy, while the rest underwent open surgery. The mean Pheochromocytoma of Adrenal gland Scaled Score (PASS) was 3.41 ± 0.28, and 23% had a high risk for malignancy. Among perioperative complications, hypertension crisis (17%) was the most common, followed by posoperative hypotension (13%), hypoglycemia (3%) and right-sided pneumothorax (3%). These patients with complications had higher metanephrine levels (5490 vs. 1880mcg/24 hours, p=0.001). Blood pressure normalized in 50%, and this was associated with male sex, younger age (29.5 vs. 40 years, p=0.03), higher metanephrines (4619 vs. 1855mcg/24 hours, p=0.001) and smaller tumors (5.91 vs. 8.61cm, p=0.046). PASS score greater than or equal to 4 was associated with higher metanephrine levels (5104 vs. 2312mcg/24 hours, p=0.021) and larger tumors (9.28 vs. 6.68 cm, p=0.024). Biochemical cure rate was achieved in 76% of patients after surgery and was associated with older age (37.7 years vs. 27.7 years, p=0.047) and absence of pheochromocytoma spells (100% vs. 61%, p=0.014). Conclusion. Young age, smaller tumor size and higher metanephrine concentrations were associated with normalization of blood pressure post-surgery. On the other hand, older patients and those without pheochromocytoma spells had better biochemical cure rates. Patients with higher baseline metanephrine levels had increased perioperative complications. More aggressive tumor behavior was associated with higher metanephrine levels and larger tumors. Sex, baseline blood pressure and mode of surgery did not have any influence on treatment outcomes.

Surgical outcomes in the pheochromocytoma surgery. Results from the PHEO-RISK STUDY

Risk Factors for Perioperative Complications, Treatment Outcomes and Aggressive Behavior of the Tumor in Patients with Pheochromocytoma

Role of preoperative adrenergic blockade with doxazosin on hemodynamic control during the surgical treatment of pheochromocytoma: a retrospective study of 48 cases

Adrenalectomy for pheochromocytoma: Surgical outcomes and preoperative risk factors for hemodynamic instability

Surgery for pheochromocytoma: A 20-year experience of a single institution

Outcomes for Patients with Obesity Undergoing Adrenalectomy for Pheochromocytoma: An International Multicenter Analysis

Glycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas

Hemorrhage in Pheochromocytoma Surgery: Evaluation of Preoperative Risk Factors

Anesthetic management for surgical treatment of pheochromocytoma

Perioperative management for pheochromocytoma

Identification of risk factors for postoperative persistent hypertension in patients with pheochromocytoma

Robotic and Laparoscopic Adrenalectomy for Pheochromocytoma: An International Multicenter Study

Risk Factors of Postoperative Complications after Laparoscopic Surgery for Pheochromocytoma

Surgical Treatment of Pheochromocytoma (report of 151 Cases)

Omitting the Escalating Dosage of Alpha-adrenergic Blockade before Pheochromocytoma Resection: Implementation of a Treatment Strategy in Discordance with Current Guidelines

Pheochromocytoma: Clinical Experience From a Single Tertiary Care Center in India

Surgical treatment of 137 cases of pheochromocytoma/paraganglioma: outcome analysis and clinical experience from a single institution

The Surgical and Peri-operative Treatment of Pheochromocytoma

International multicentre review of perioperative management and outcome for catecholamine-producing tumours

Resection of Pheochromocytoma Improves Diabetes Mellitus in the Majority of Patients

Preoperative Risk Factors for Haemodynamic Instability During Pheochromocytoma Surgery in Chinese Patients.